Inhibition of HIV Type 1 Replication Using Lentiviral-Mediated Delivery of Mutant tRNA Lys3 A58U
Authors:
- 1 December 2004
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 20 (12) , 1324-1334
Abstract
In previous studies, we showed that residue A58 of cellular tRNALys3 is necessary for appropriate termination of viral plus-strand strong-stop DNA (+SS DNA), and therefore plays a critical role in the life cycle of HIV-1. We also performed proof-of-principle studies that established that a mutant form of this tRNA primer (tRNALys3A58U, which lacks the M1A58 residue necessary for +SS DNA termination) could inhibit HIV-1 replication. In the present work, we examined whether a third generation lentiviral vector (SIN) could be used to deliver tRNALys3A58U to CEM cells. Using both viral kinetic studies and limiting dilution assays (LDA), we observed significant impairment of HIV-1 replication, up to 3 logs in the LDA, in CEM sublines expressing mutant tRNALys3A58U. No inhibition occurred in cells that either expressed wild-type tRNALys3 or were transduced with empty SIN vector. Further, we observed impairment of viral replication using primary isolates of both HIV-1 and HIV-2 in sublines containing tRNALys3A58U. We also detected "breakthrough" HIV-1 replication in some tRNALys3A58U-expressing cultures. Interestingly, analyzed breakthrough viruses appeared to be both genetically and phenotypically wild type. One possible explanation for virological breakthrough is that it reflects the gradual accumulation of HIV-1 within the infected cell culture, to a level that ultimately exceeds the containment "threshold" conferred by tRNALys3A58U. The fact that HIV-1 does not appear to acquire heritable resistance to tRNALys3A58U-mediated blockade differentiates this antiviral modality from other therapeutic interventions. It also suggests that tRNA-mediated inhibition of viral replication might be a valuable adjunct to other antiviral approaches.Keywords
This publication has 26 references indexed in Scilit:
- Enhanced Expression and HIV-1 Inhibition of Chimeric tRNALys3-Ribozymes under Dual U6 snRNA and tRNA PromotersMolecular Therapy, 2002
- tRNALys3: The Primer tRNA for Reverse Transcription in HIV‐1IUBMB Life, 2002
- Mutation of the Methylated tRNA3Lys Residue A58 Disrupts Reverse Transcription and Inhibits Replication of Human Immunodeficiency Virus Type 1Journal of Virology, 2001
- Initiation of HIV-1 Reverse Transcription Is Regulated by a Primer Activation SignalJournal of Biological Chemistry, 2001
- Role of Post-transcriptional Modifications of Primer tRNALys,3 in the Fidelity and Efficacy of Plus Strand DNA Transfer during HIV-1 Reverse TranscriptionJournal of Biological Chemistry, 1999
- It's Prime Time for Reverse TranscriptaseCell, 1997
- Multiple Forms of tRNALys3in HIV-1Biochemical and Biophysical Research Communications, 1996
- Initiation of Reverse Transcripion of HIV-1: Secondary Structure of the HIV-1 RNA/tRNA|rlmbopopnbop|Lys|clobop|3 (Template/Primer) ComplexJournal of Molecular Biology, 1995
- Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNALys as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotidesJournal of Molecular Biology, 1992
- A detailed model of reverse transcription and tests of crucial aspectsCell, 1979